Haematologica
(Aug 2017)
Low frequency mutations in ribosomal proteins RPL10 and RPL5 in multiple myeloma
- Isabel J.F. Hofman,
- Stephanie Patchett,
- Mark van Duin,
- Ellen Geerdens,
- Jelle Verbeeck,
- Lucienne Michaux,
- Michel Delforge,
- Pieter Sonneveld,
- Arlen W. Johnson,
- Kim De Keersmaecker
Affiliations
- Isabel J.F. Hofman
- Department of Oncology, KU Leuven - University of Leuven, LKI - Leuven Cancer Institute, Belgium
- Stephanie Patchett
- Department of Molecular Biosciences, The University of Texas at Austin, TX, USA
- Mark van Duin
- Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands
- Ellen Geerdens
- Center for Cancer Biology, VIB, Leuven, Belgium;Center for Human Genetics, KU Leuven - University of Leuven, LKI - Leuven Cancer Institute, Belgium
- Jelle Verbeeck
- Department of Oncology, KU Leuven - University of Leuven, LKI - Leuven Cancer Institute, Belgium
- Lucienne Michaux
- Center for Human Genetics, KU Leuven - University Hospitals Leuven, Belgium
- Michel Delforge
- LKI - Leuven Cancer Institute, Department of Development and Regeneration, KU Leuven - University Hospitals Leuven, Belgium
- Pieter Sonneveld
- Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands
- Arlen W. Johnson
- Department of Molecular Biosciences, The University of Texas at Austin, TX, USA
- Kim De Keersmaecker
- Department of Oncology, KU Leuven - University of Leuven, LKI - Leuven Cancer Institute, Belgium
- DOI
-
https://doi.org/10.3324/haematol.2016.162198
- Journal volume & issue
-
Vol. 102,
no. 8
WeChat QR code